Compassus is a national home-based care company headquartered in Brentwood, Tennessee, delivering hospice, palliative care, home health and home infusion services to patients wherever they call home. Jointly owned by TowerBrook Capital Partners and the Catholic health system Ascension, Compassus operates across roughly 30 states with about 8,000 employees and has built its growth around joint ventures with major health systems - including OhioHealth, Providence and Ascension - so that hospitals can extend care into the home under a shared brand while Compassus runs the clinical operations.
David Bell is the founder and CEO of IO Health, a Pasadena-based AI startup building a real-time workflow intelligence layer that sits on top of existing EMRs to help home health and hospice clinicians document care accurately at the point of care. Before IO Health he spent roughly a decade as owner-operator and CEO of GrandCare Health Services, which he grew into a 5-star-rated Southern California home health provider before it was acquired by The Pennant Group in 2025. An engineer-turned-operator with degrees spanning physics, business, and rehabilitation robotics, Bell raised a $2M seed round led by Nina Capital in October 2025 to scale IO Health's compliance and quality platform.
Mike Asselta is the chief executive officer of Compassus, one of the largest home-based care companies in the United States, spanning home health, hospice, palliative care and infusion therapy across some 200 locations. Appointed in May 2024, he came from nearly eight years at Fresenius Medical Care North America, where he ran U.S. care delivery and Fresenius Kidney Care - an operation of more than 60,000 employees and 4,000 sites. At Compassus he has bet the company's growth on joint ventures with major health systems like Providence and OhioHealth, arguing that the future of care happens where people actually live: at home.
ExaCare AI is a New York-based healthcare technology company building an AI operating system for post-acute and senior care. Its suite of AI agents reads messy referral packets, recommends patient placements, automates reimbursement and documentation, and surfaces clinical risk so that care teams in skilled nursing, home health, and hospice spend less time on paperwork and more time on patients. Founded in 2022 by Laird Russell and Ben Willox, the company powers roughly 1,500-2,000 facilities nationwide and raised a $30M Series A led by Insight Partners in October 2025.
Brellium is a New York-based healthcare technology company building an AI-powered clinical and payor compliance platform. Its software audits 100% of patient charts against custom quality, coding, and billing standards in real time - flagging issues like copy-pasted notes, contraindicated medications, incorrect session lengths, and declining patient conditions before they trigger payor clawbacks or quality failures. Founded after CEO Zach Rosen's own costly medical misdiagnosis, Brellium serves behavioral health, mental health, ABA therapy, and hospice providers, and raised a $16.7M Series A in April 2025 led by First Round Capital and Left Lane Capital.
Bristol Hospice is a Salt Lake City-based provider of hospice and palliative care that has grown from a single Utah location in 2006 into a national operator running roughly 78-80 locations across 25 states. Backed by private equity firm Webster Equity Partners, it offers adult and pediatric hospice, palliative care, and specialty comfort programs for dementia, respiratory disease, sleep, and veterans, with a mission centered on compassion, respect, and 'a reverence for life.'
Alex Mauricio is the President and CEO of Bristol Hospice, one of the largest and fastest-growing hospice organizations in the United States, spanning approximately 80 locations across 25 states. With 20+ years in healthcare and 13+ years in hospice, Mauricio rose through the ranks from home care roots to leading a $214M-funded organization of ~2,500 employees. He became CEO in February 2023, succeeding founder Hyrum Kirton, and has since driven aggressive acquisition-led expansion while championing specialty programs including pediatric hospice, COPD-focused care, and palliative services.